Timeline
2022.01
2022
- Registered in Israel
- Participated in the 1st Aesthetic & Anti-Aging Medicine World Congress Japan as a Platinum Sponsor.
- TESS Launch in the Middle East.
2021.01
2021
- Establishment of TESS LAB at Wonju Medical Industry Techno Valley.
- TESS Launch in Spain
2020.01
2020
- Company name “TESS Co., Ltd.” has changed to extend the manufacturing portfolio.
- Showcasing at the 18th Aesthetic & Anti-Aging Medicine World Congress as a Gold Sponsor.
- CE approved – TESS SOFT (All of the TESS products)
2019.01
2019
- Showcased at the Dubai World Dermatology & Laser Conference & Exhibition, Dubai Derma 2019.
- Invited to speak at the 43rd Japan Society of Aesthetic Plastic Surgery.
- CE registration for TESS-160 & TESS-020 by UDEM
- Showcased at the 2019 International Congress of Aesthetic Dermatology.
2018.01
2018
- Business Agreement for the Exclusivity of TESS Products with Zishel Group for the globalization of TESS products.
- Clinical Trial for TESS SOFT.
- invited to speak at the 106th Japan Society of Aesthetic Surgery in Tokyo.
- Showcased at the 2018 International Congress of Aesthetic Dermatology.
2017.01
2017
- Entitled to ISO 13485 certification (TUV SUD, Germany) for Wonju plant (KFDA).
- Initial Partner Agreement with Samsung Seoul Hospital for Government R&D project.
- Registered absorbable TESS SOFT products by Ministry of Food and Drug Safety.
- Patent registration for”Device for Tissue Suspension and Fixation”
- Appointed Hee Jang, BL as the CEO of TESS Co., Ltd. for his expertise in trading and laws.
- Showcased at the 15th Aesthetic & Anti-aging Medicine, AMWC.
2015.01
2015-2016
- Registered 2-dimensional non-absorbable TESS-020 and TL-010 delivery devices products by Ministry of Food and Drug Safety (KFDA).
- Registered 3-dimensional non-absorbable TESS-160 and U Lift-060 products by Ministry Food and Drug Safety (KFDA).
- Invited to speak at EAM, Indonesia Aesthetic Medicine.
- Registered absorbable V Lift products by Ministry of Food and Drug Safety (KFDA).
- Business Agreement for U Lift-060 and V lift products with DN Company, subsidiary of Daewoong Pharm.
- Showcased at the 2016 International Congress of Korea-Japan-China Aesthetic Surgery & Medicine.
- Showcased at the 33rd The Congress of Korean Society of Aesthetic Surgery.
- Established the Corporate R&D Center for implant for tissue suspension.
- Corporate R&D Center Accreditation by Korea Industrial Technology Association (KOITA).
2014.01
2014
- Showcased at the 2nd Congress of Asia Anti-Aging & Regenerative Medicine.
- Showcased at the Asia Forum for Aestheic Surgery & Medicine.
- Showcased at the 11th Congress of Eastern Cosmetic Surgery.
- Entitled to KGMP certification on Wonju plant.
- Registered 2-dimensional non-absorbable TESS-010 product by Ministry of Food and Drug Safety (KFDA).
2013.01
2013
- International trademarks registrations for Madrid (Associated countries: Australia, China, EU, Japen, Russia, USA)
- Live demonstration lecure for TESS’s products at the 26th Congress of Korean Society of Aestheic Surgery.
- Established the first plant and head office at Wonju Medical Industry Techno Valley.
- Registered for manufacturing business for medical devices.
2012.01
2012
- Patent PCT International Application for “Graft for Tissue Lifting” 9PCT/KR2012/004421
- Established the OEM Agreement for registered TESS products.
- Appointed Dr. Min Kim, MD, as the CEO and Medical Advisory Board Chair of TESS Co., Ltd. to foster the R&D for TESS’s products portfolio.
- Showcased at the 4th International Congress of Minimally Invasive Plastic Surgery.
- Live demonstration lecture for TESS products at the 25th Congress of Korean Society of Aesthetic Sugery.
2008.01
2007-2008
- Collaborations among biomedical engineers and surgeons have established R&D of an implant for tissue suspention.
- Company name “Jimmy Kim Corp.” has changed to “TESS Co., Ltd.” (former CEO. Jimmy Kim, the bio-medical engineer).
